PA
MIRM icon

Parallel Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History

Parallel Advisors’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83.5K Buy
713
+266
+60% +$26.7K ﹤0.01% 1817
2026
Q1 		$41.3K Hold
447
– – ﹤0.01% 2097
2025
Q4 		$35.3K Hold
447
– – ﹤0.01% 2030
2025
Q3 		$32.8K Buy
447
+7
+2% +$445 ﹤0.01% 2010
2025
Q2 		$22.4K Hold
440
– – ﹤0.01% 2140
2025
Q1 		$19.8K Sell
440
-2
-0.5% -$94 ﹤0.01% 2147
2024
Q4 		$18.3K Buy
442
+2
+0.5% +$83 ﹤0.01% 2184
2024
Q3 		$17.2K Buy
440
+24
+6% +$957 ﹤0.01% 2176
2024
Q2 		$14.2K Hold
416
– – ﹤0.01% 2167
2024
Q1 		$10.4K Hold
416
– – ﹤0.01% 2293
2023
Q4 		$12.3K Sell
416
-20
-5% -$605 ﹤0.01% 2204
2023
Q3 		$13.8K Hold
436
– – ﹤0.01% 2043
2023
Q2 		$11.3K Hold
436
– – ﹤0.01% 2119
2023
Q1 		$10.5K Buy
436
+36
+9% +$821 ﹤0.01% 2108
2022
Q4 		$7.8K Hold
400
– – ﹤0.01% 2133
2022
Q3 		$8K Hold
400
– – ﹤0.01% 2092
2022
Q2 		$8K Hold
400
– – ﹤0.01% 2088
2022
Q1 		$9K Hold
400
– – ﹤0.01% 2072
2021
Q4 		$6K Sell
400
-553
-58% -$8.6K ﹤0.01% 2333
2021
Q3 		$19K Hold
953
– – ﹤0.01% 1765
2021
Q2 		$16K Buy
953
+553
+138% +$9.91K ﹤0.01% 1798
2021
Q1 		$8K Hold
400
– – ﹤0.01% 2016
2020
Q4 		$7K Hold
400
– – ﹤0.01% 1932
2020
Q3 		$8K Hold
400
– – ﹤0.01% 1836
2020
Q2 		$7K Hold
400
– – ﹤0.01% 1850
2020
Q1 		$5K Hold
400
– – ﹤0.01% 1906
2019
Q4 		$10K Buy
+400
New +$4.26K ﹤0.01% 1728

Other funds holding MIRM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Parallel Advisors's MIRM Position: Q2 2026 in Review

Parallel Advisors increased its Mirum Pharmaceuticals (MIRM) stake by 60% in Q2 2026, buying an estimated $26.7K and bringing the position to 713 shares worth $83.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1817.

Parallel Advisors first reported a position in MIRM in Q4 2019 and has held it in 27 quarters since. 226 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Parallel Advisors held 713 shares of Mirum Pharmaceuticals worth $83.5K as of Q2 2026.
  • Parallel Advisors bought 266 Mirum Pharmaceuticals shares in Q2 2026, an estimated $26.7K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #1817 holding.
  • Parallel Advisors first reported a position in Mirum Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
  • 226 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.